Sivi Ouwerkerk-Mahadevan

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 2

Top Topics

Patient Reported

Prognostic Factors

Ejection Fraction

Multiple Sclerosis

Top Venues

Clinical pharmacokinetics

This page only lists publications with an associated author ORCID identifier.

Publications

Terra M Kruger, Belén Valenzuela, Charles D Thompson, Sivi Ouwerkerk-Mahadevan, Juan Jose Perez Ruixo
Clinical Pharmacokinetics of Ponesimod, a Selective S1P1 Receptor Modulator, in the Treatment of Multiple Sclerosis. Clinical pharmacokinetics (2023)
Belén Valenzuela, Juan Jose Perez Ruixo, Quentin Leirens, Sivi Ouwerkerk-Mahadevan, Italo Poggesi
Effect of Ponesimod Exposure on Total Lymphocyte Dynamics in Patients with Multiple Sclerosis. Clinical pharmacokinetics 60 (9) (2021)